Burning Rock Biotech (Burning Rock Biotech) EBIT per Share : $-0.88 (TTM As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Burning Rock Biotech EBIT per Share?

Burning Rock Biotech's EBIT per Share for the three months ended in Dec. 2023 was $-0.20. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.88.

During the past 3 years, the average EBIT per Share Growth Rate was 0.10% per year. During the past 5 years, the average EBIT per Share Growth Rate was -13.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Burning Rock Biotech's EBIT per Share or its related term are showing as below:

BNR' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -69.5 Med: -32.5 Max: 0.1
Current: 0.1

During the past 7 years, the highest 3-Year average EBIT per Share Growth Rate of Burning Rock Biotech was 0.10% per year. The lowest was -69.50% per year. And the median was -32.50% per year.

BNR's 3-Year EBIT Growth Rate is ranked worse than
50.56% of 180 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.3 vs BNR: 0.10

Burning Rock Biotech's EBIT for the three months ended in Dec. 2023 was $-20.77 Mil.

Burning Rock Biotech EBIT per Share Historical Data

The historical data trend for Burning Rock Biotech's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Burning Rock Biotech EBIT per Share Chart

Burning Rock Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

-0.26

-0.91

-1.20

-1.35

-0.89

Burning Rock Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EBIT per Share	Get a 7-Day Free Trial															-0.30	-0.26	-0.18	-0.24	-0.20

Burning Rock Biotech EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Burning Rock Biotech's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-91.216	/	102.397
=	-0.89

Burning Rock Biotech's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-20.77	/	102.399
=	-0.20

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.88

Burning Rock Biotech (NAS:BNR) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Burning Rock Biotech EBIT per Share Related Terms

Thank you for viewing the detailed overview of Burning Rock Biotech's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Burning Rock Biotech (Burning Rock Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Burning Rock Biotech Ltd (NAS:BNR) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

BNR:UK 6BUA:Germany

Address

No. 5, Xingdao Ring Road North, International Bio Island, Guangzhou, CHN, 510005

Website

https://www.brbiotech.com

Burning Rock Biotech Ltd is a cancer diagnostics company. Its products include OncoScreen Plus and ColonCore. The company has developed various cancer detection products, involving tumor targeting, differentiation of benign and malignant tumors, monitoring of small residual lesions, prediction of tumor recurrence progress, and detection of tumor sensitivity. It offers 12 NGS-based cancer therapy selection tests comprising a broad range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer, using both tissue and liquid biopsy samples.